Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Benitec Biopharma stock
Learn how to easily invest in Benitec Biopharma stock.
Benitec Biopharma Inc is a biotechnology business based in the US. Benitec Biopharma shares (BNTC) are listed on the NASDAQ and all prices are listed in US Dollars. Benitec Biopharma employs 14 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Benitec Biopharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BNTC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Benitec Biopharma stock price (NASDAQ: BNTC)Use our graph to track the performance of BNTC stocks over time.
Benitec Biopharma shares at a glance
|Latest market close||$2.49|
|52-week range||$2.30 - $10.49|
|50-day moving average||$2.99|
|200-day moving average||$3.84|
|Wall St. target price||$14.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.67|
Buy Benitec Biopharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Benitec Biopharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Benitec Biopharma price performance over time
|1 week (2022-01-13)||N/A|
|1 month (2021-12-23)||-16.44%|
|3 months (2021-10-20)||N/A|
|6 months (2021-07-23)||-33.95%|
|1 year (2021-01-22)||-41.82%|
|2 years (2020-01-23)||-46.45%|
|3 years (2019-01-23)||64.20%|
|5 years (2017-01-23)||33.55%|
Benitec Biopharma financials
|Gross profit TTM||$-64,000|
|Return on assets TTM||-73.49%|
|Return on equity TTM||-139.67%|
|Market capitalisation||$20.9 million|
TTM: trailing 12 months
Benitec Biopharma share dividends
We're not expecting Benitec Biopharma to pay a dividend over the next 12 months.
Have Benitec Biopharma's shares ever split?
Benitec Biopharma's shares were split on a 2:3 basis on 14 April 2020. So if you had owned 3 shares the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Benitec Biopharma shares – just the quantity. However, indirectly, the new 50% higher share price could have impacted the market appetite for Benitec Biopharma shares which in turn could have impacted Benitec Biopharma's share price.
Benitec Biopharma share price volatility
Over the last 12 months, Benitec Biopharma's shares have ranged in value from as little as $2.3 up to $10.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Benitec Biopharma's is 1.5874. This would suggest that Benitec Biopharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Benitec Biopharma overview
Benitec Biopharma Inc. , a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California. .
Benitec Biopharma in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Benitec Biopharma : Submission of Matters to a Vote of Security Holders - Form 8-K/A
BENITEC BIOPHARMA INC. Submission of Matters to a Vote of Security Holders (form 8-K/A)
Frequently asked questionsWhat percentage of Benitec Biopharma is owned by insiders or institutions?
Currently 9.923% of Benitec Biopharma shares are held by insiders and 23.951% by institutions. How many people work for Benitec Biopharma?
Latest data suggests 14 work at Benitec Biopharma. When does the fiscal year end for Benitec Biopharma?
Benitec Biopharma's fiscal year ends in June. Where is Benitec Biopharma based?
Benitec Biopharma's address is: 3940 Trust Way, Hayward, CA, United States, 94545 What is Benitec Biopharma's ISIN number?
Benitec Biopharma's international securities identification number is: US08205P1003 What is Benitec Biopharma's CUSIP number?
Benitec Biopharma's Committee on Uniform Securities Identification Procedures number is: 082053208
More guides on Finder
Dogecoin jumps 10% on word you can use it to buy Tesla merch
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
Thursday’s top U.S. stocks: Taiwan Semiconductor Manufacturing Company Ltd. (TSM ↑8.4%), Lam Research Corporation (LRCX ↑6.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Ask an Expert